Dementia with Lewy Bodies

Plasma p-tau181 to identify Alzheimer’s disease-related co-pathology in DLB

A review of current clinical trials in dementia with Lewy bodies

Identifying dementia with Lewy bodies in the presence of Alzheimer’s disease

Implementing novel clinical trial designs for dementia with Lewy bodies

Challenges in designing clinical trials for dementia with Lewy bodies

Next steps in dementia biomarkers

Phase II study of S2R modulation in patients with dementia with Lewy bodies

Biomarkers in dementia with Lewy bodies: αSyn RT-QuIC

Diagnostic performance of GFAP in CSF, plasma, and serum with age

Characterizing the prodromal phase of dementia with Lewy bodies

A practical approach to cognitive impairment management

Diagnostic tools for neurodegenerative disease

Clinical characteristics of dementia with Lewy bodies

Criteria for the diagnosis and management of dementia with Lewy bodies

The future landscape of biomarkers for dementia diagnosis

Combining gait with other biomarkers for dementia